Poniard Pharmaceuticals Inc
OTC:PARD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Poniard Pharmaceuticals Inc
OTC:PARD
|
US |
|
S
|
Santander Bank Polska SA
WSE:SPL
|
PL |
|
Omid Holdings Inc
OTC:OMID
|
US |
|
A
|
AUR Portfolio III SE & Co KgaA
XHAM:AR40
|
DE |
|
Minim Inc
OTC:MINM
|
US |
|
PhaseBio Pharmaceuticals Inc
OTC:PHASQ
|
US |
|
Pacific Financial Corp
OTC:PFLC
|
US |
|
SOLAR FABRIK AG FUER PRODUKTION UND VERTRIEB VON SOLARTECh PROD
F:SFX
|
DE |
|
K
|
Karolinska Development AB
STO:KDEV
|
SE |
|
New Tripoli Bancorp Inc
OTC:NTBP
|
US |
|
Nuvve Holding Corp
OTC:NVVE
|
US |
|
FiscalNote Holdings Inc
OTC:NOTE
|
US |
|
C
|
ChargePanel AB (publ)
STO:CHARGE
|
SE |
|
Nanomix Corp
OTC:NNMX
|
US |
|
Oconomowoc Bancshares Inc
OTC:OCNB
|
US |
|
P
|
Panamera Holdings Corp
OTC:PHCI
|
US |
|
Comsys Holdings Corp
TSE:1721
|
JP |
|
Nu-Med Plus Inc
OTC:NUMD
|
US |
|
Mission Bancorp
OTC:MSBC
|
US |
|
C
|
Corticeira Amorim SGPS SA
XMUN:AS4
|
PT |
|
K
|
KK Softfront Holdings
TSE:2321
|
JP |
Bankruptcy Probability
Poniard Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Poniard Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
P
|
Poniard Pharmaceuticals Inc
OTC:PARD
|
149.9 USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
439.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
225.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
168.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
133.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
66.3B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Poniard Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Poniard Pharmaceuticals Inc has total debt of 1.6m USD. This includes both short-term (0 USD) and long-term (1.6m USD) debt.
You can find a full breakdown on its Balance Sheet.
